Caladrius Biosciences, Inc. Gains 77.3%
Wed, Jan 20, 2021 at 05:30 PM
Caladrius Biosciences, Inc. (CLBS:NASDAQ) soared at $2.89, a gain of 77.3%. On Tue 19 Jan 21, CLBS:NASDAQ hit a New 2-Week High of $1.63. The stock got featured on our News Catalysts scanner on Tue 19 Jan 21 at 09:53 AM in the 'BIOTECH' category. From Tue 05 Jan 21, the stock recorded 66.67% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Caladrius Biosciences, Inc. (CLBS:NASDAQ)
Caladrius Biosciences Inc is a biopharmaceutical company. The company through its subsidiary is developing cellular therapeutics to treat diseases.
Top 10 Gainers:
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 414.29%
- Steel Connect, Inc. (STCN:NASDAQ), 79.19%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 77.64%
- Caladrius Biosciences, Inc. (CLBS:NASDAQ), 77.3%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 74.93%
- 36Kr Holdings Inc. (KRKR:NASDAQ), 74.92%
- Titan Medical Inc. (TMDI:NASDAQ), 52.41%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 49.21%
- Globalstar, Inc. (GSAT:NYSEMKT), 48.59%
- YQ (YQ:NASDAQ), 48.24%